Caffeine and allergy medication are both widely used in the UK, yet few patients consider how combining them might affect their treatment. Caffeine — found in coffee, tea, energy drinks, and some over-the-counter remedies — acts as a central nervous system stimulant that can interact with antihistamines, decongestants, and other allergy medicines in clinically relevant ways. Whether caffeine reduces the sedative effect of older antihistamines or compounds the stimulant action of decongestants, understanding these interactions helps patients use their allergy treatments more safely and effectively. This article explains the key interactions, who is most at risk, and when to seek professional advice.

How Caffeine May Interact With Common Allergy Medications

Caffeine is one of the most widely consumed psychoactive substances in the world, found in tea, coffee, energy drinks, and certain over-the-counter medicines. When taken alongside allergy medications, caffeine can influence how the body responds to treatment — sometimes in ways that are clinically relevant, though not always well understood by patients.

Caffeine acts primarily as an adenosine receptor antagonist, blocking the calming effects of adenosine in the brain and central nervous system. This stimulant action can counteract or amplify the effects of certain allergy medicines, depending on their pharmacological class. For example, older, sedating antihistamines work partly by crossing the blood-brain barrier and causing drowsiness — an effect that caffeine may partially offset. Conversely, caffeine's stimulant properties may compound side effects such as increased heart rate or restlessness when combined with decongestants.

It is important to note that there is no official regulatory warning from the MHRA or EMA specifically prohibiting caffeine consumption alongside most standard allergy medications. However, the absence of such a prohibition does not mean the combination is without risk for all individuals — patients should always read the patient information leaflet (PIL) supplied with their medicine and check with a pharmacist if unsure. The interaction is pharmacologically plausible and worth understanding.

The European Food Safety Authority (EFSA) considers up to 400 mg of caffeine per day (roughly three to four cups of coffee) to be generally safe for healthy adults, though caffeine content varies considerably between beverages and products. Patients who consume high amounts of caffeine daily may notice altered medication effects or unexpected side effects. It is also worth noting that some over-the-counter combination products (for example, certain cold and flu remedies) already contain caffeine, which can unintentionally increase total daily intake. Being aware of these potential interactions allows for more informed, safer use of allergy treatments.

Types of Allergy Medication Available in the UK

In the UK, allergy medications are available across several pharmacological categories, many of which can be purchased over the counter from pharmacies or prescribed by a GP. Understanding the different types helps clarify where caffeine interactions may be most relevant.

Antihistamines are the most commonly used allergy medicines and are divided into two main groups:

• First-generation (sedating) antihistamines — such as chlorphenamine (Piriton) and promethazine. These cross the blood-brain barrier and commonly cause drowsiness. They also have anticholinergic properties, which can cause side effects such as dry mouth and urinary hesitancy.

• Second-generation (non-sedating) antihistamines — such as cetirizine, loratadine, and fexofenadine. These are less likely to cause sedation and are generally preferred for daytime use, in line with NICE CKS guidance on allergic rhinitis.

Nasal corticosteroids, such as beclometasone (Beconase) and fluticasone (Flixonase), are recommended by NICE CKS as first-line treatment for moderate-to-severe allergic rhinitis. They work by reducing local inflammation in the nasal passages and have minimal systemic absorption.

Decongestants, such as pseudoephedrine (oral) and xylometazoline (nasal spray), are used to relieve nasal congestion. They act on adrenergic receptors to constrict blood vessels. Topical nasal decongestants such as xylometazoline should not be used for more than seven days continuously, as prolonged use can cause rebound congestion (rhinitis medicamentosa). Oral decongestants carry additional cautions, particularly in patients with cardiovascular conditions.

Leukotriene receptor antagonists, such as montelukast, may be prescribed for patients with seasonal allergic rhinitis who also have concomitant asthma; montelukast is not generally recommended as monotherapy for allergic rhinitis alone in UK clinical practice. The MHRA has issued a Drug Safety Update (2022) highlighting the risk of neuropsychiatric reactions with montelukast — including sleep disturbances, mood changes, and suicidal thoughts — and advises that patients and carers should be counselled about these risks before starting treatment.

Other treatments, including sodium cromoglicate nasal spray, intranasal antihistamines, and combination intranasal azelastine/fluticasone preparations, may also be used in appropriate circumstances. Each medication type carries a distinct side-effect profile, and the relevance of caffeine as a co-factor varies accordingly.

Effects of Combining Caffeine With Antihistamines

The interaction between caffeine and antihistamines is perhaps the most clinically discussed aspect of caffeine and allergy medication use. The nature of the interaction depends significantly on whether the antihistamine is sedating or non-sedating.

With first-generation antihistamines such as chlorphenamine, drowsiness is a well-recognised and sometimes intended side effect — particularly when used to manage night-time allergy symptoms or urticaria. These medicines also have anticholinergic properties (not shared by caffeine), which can cause dry mouth, urinary hesitancy, and blurred vision. Caffeine, as a central nervous system stimulant, may reduce the perceived sedative effect of these antihistamines. Whilst this might seem beneficial, it can lead to unpredictable alertness levels and may give patients a false sense of their ability to drive or operate machinery safely. Importantly, caffeine may reduce the sensation of drowsiness without fully restoring psychomotor performance. Patient information leaflets for sedating antihistamines typically advise: if this medicine causes drowsiness, do not drive or operate machinery. Patients should follow this PIL advice regardless of whether they feel alert, and should consult the NHS guidance on medicines and driving if in doubt.

With second-generation antihistamines such as cetirizine or loratadine, the interaction with caffeine is generally considered less significant, as these medicines have a lower propensity to cause sedation. However, some individuals — particularly those sensitive to caffeine — may still experience heightened restlessness, difficulty sleeping, or palpitations when combining high caffeine intake with these medications.

Patients are advised to:

• Monitor their caffeine intake during allergy treatment

• Avoid caffeine close to bedtime if taking any antihistamine

• Follow the PIL advice on driving and operating machinery

• Report unusual symptoms such as palpitations or difficulty sleeping to their pharmacist

Who Should Be Cautious About Caffeine Intake During Treatment

Whilst most healthy adults can consume moderate amounts of caffeine without significant concern during allergy treatment, certain groups should exercise greater caution. Understanding individual risk factors helps patients and clinicians make more tailored decisions.

People taking decongestants — such as pseudoephedrine — should be particularly mindful of caffeine intake. Both substances can raise heart rate and blood pressure through stimulant mechanisms. Combining them may increase the risk of cardiovascular side effects, including palpitations, anxiety, and hypertension. This is especially relevant for individuals with pre-existing cardiovascular conditions; NICE CKS guidance on allergic rhinitis advises caution with oral decongestants in patients with hypertension or heart disease, and the NHS recommends that such patients seek advice from a pharmacist or GP before use.

Older adults may be more sensitive to both caffeine and antihistamine side effects, including confusion, urinary retention, and increased falls risk — particularly with first-generation antihistamines. High caffeine intake in this group may further disrupt sleep and exacerbate anxiety.

Pregnant women should note that caffeine intake is already recommended to be limited to under 200 mg per day (approximately two cups of coffee) by the NHS. Many allergy medications also carry specific guidance during pregnancy — for example, oral decongestants are generally not recommended, and if an antihistamine is needed, loratadine or cetirizine are usually preferred following discussion with a GP or midwife. The combination of caffeine and allergy medication during pregnancy warrants careful discussion with a healthcare professional.

Children and adolescents using allergy medications should have caffeine intake monitored, as energy drinks and caffeinated beverages are increasingly common in younger age groups. The interaction between caffeine and sedating antihistamines in children may produce unpredictable behavioural effects. Parents and carers should always follow age-appropriate dosing guidance and consult a pharmacist before combining any substances.

Advice From NHS and MHRA on Managing Allergy Medication Safely

The NHS and MHRA provide clear guidance on the safe use of allergy medications, though specific advice on caffeine co-consumption is not always explicitly detailed in patient information leaflets. Nevertheless, broader safety principles apply and are worth highlighting.

The MHRA regulates all medicines sold in the UK and requires that patient information leaflets (PILs) include details of known interactions and contraindications. Patients are encouraged to read PILs carefully before taking any allergy medication. Suspected side effects from any medicine should be reported via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk. This scheme helps identify emerging safety signals, including those related to lifestyle factors such as caffeine.

The NHS recommends that patients with persistent or severe allergy symptoms seek a formal diagnosis rather than relying solely on over-the-counter treatments. NICE CKS guidance on allergic rhinitis (hay fever) supports a stepwise approach to management, beginning with non-sedating antihistamines and nasal corticosteroids before escalating to specialist referral if symptoms remain poorly controlled.

In terms of practical safety advice:

• Do not exceed the recommended dose of any allergy medication

• Avoid alcohol when taking sedating antihistamines, as the combination significantly increases sedation

• Limit caffeine if you notice increased heart rate, anxiety, or sleep disturbance during treatment

• Check all products you are taking, including cold and flu remedies, as some already contain caffeine

• Inform your pharmacist of all substances you are consuming, including caffeinated supplements or energy drinks

These measures support safe, effective allergy management within the framework of UK clinical guidance.

When to Speak to a GP or Pharmacist

For most people, managing allergy symptoms with over-the-counter medication and moderate caffeine intake is straightforward and safe. However, there are specific circumstances in which professional advice should be sought promptly.

If you experience any of the following signs of a severe allergic reaction (anaphylaxis), call 999 or go to A&E immediately:

• Difficulty breathing or swallowing

• Swelling of the tongue, lips, or throat

• Dizziness, collapse, or loss of consciousness

• A widespread rash with any of the above symptoms

Contact your GP or pharmacist if you experience:

• Palpitations, chest tightness, or an unusually rapid heartbeat during allergy treatment

• Severe drowsiness or difficulty waking, particularly if taking sedating antihistamines

• Worsening anxiety, restlessness, or insomnia that coincides with starting a new allergy medication

• Mood changes, sleep disturbances, or any neuropsychiatric symptoms if taking montelukast

• Symptoms that do not improve despite two to four weeks of appropriate over-the-counter treatment, in line with NICE CKS guidance

A pharmacist is an excellent first point of contact for questions about caffeine and allergy medication interactions. They can review your full medication list, including supplements and herbal remedies, and advise on the most appropriate allergy treatment for your circumstances. In England, the Pharmacy First service allows patients to access clinical advice for a defined range of conditions without a GP appointment; patients in Scotland and Wales can access similar support through their local minor ailment services. Please check with your pharmacist which conditions are covered under these schemes.

If allergy symptoms are significantly affecting quality of life — for example, disrupting sleep, work, or daily activities despite maximal appropriate therapy — a GP referral to an NHS allergy clinic may be appropriate. Specialist assessment can include skin-prick testing, specific IgE blood tests, and consideration of allergen immunotherapy, in line with BSACI rhinitis guidelines. Managing caffeine intake thoughtfully, alongside evidence-based allergy treatment, supports the best possible outcomes for patients across all age groups.

Frequently Asked Questions